Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:cyclophosphamide-vad regimen'
(id=7546655 ; fe=en:cyclophosphamide-vad regimen ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=644 creation date=2017-06-27 touchdate=2025-04-26 19:15:44.000)
≈ 15 relations sortantes

  1. en:cyclophosphamide-vad regimen -- r_associated #0: 21 / 1 -> en:plasma cell myeloma
    n1=en:cyclophosphamide-vad regimen | n2=en:plasma cell myeloma | rel=r_associated | relid=0 | w=21
  2. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> cyclophosphamide
    n1=en:cyclophosphamide-vad regimen | n2=cyclophosphamide | rel=r_associated | relid=0 | w=20
  3. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:bendamustine/bortezomib/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:bendamustine/bortezomib/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  4. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:bortezomib/liposomal doxorubicin regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:bortezomib/liposomal doxorubicin regimen | rel=r_associated | relid=0 | w=20
  5. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:carfilzomib/lenalidomide/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:carfilzomib/lenalidomide/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  6. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:cyclophosphamide
    n1=en:cyclophosphamide-vad regimen | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=20
  7. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:daratumumab/bortezomib/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:daratumumab/bortezomib/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  8. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:dpace regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:dpace regimen | rel=r_associated | relid=0 | w=20
  9. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:elotuzumab/bortezomib/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:elotuzumab/bortezomib/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  10. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:ixazomib/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:ixazomib/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  11. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:ixazomib/lenalidomide/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:ixazomib/lenalidomide/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  12. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:pad regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:pad regimen | rel=r_associated | relid=0 | w=20
  13. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:pomalidomide/bortezomib/dexamethasone regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:pomalidomide/bortezomib/dexamethasone regimen | rel=r_associated | relid=0 | w=20
  14. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> en:vad regimen
    n1=en:cyclophosphamide-vad regimen | n2=en:vad regimen | rel=r_associated | relid=0 | w=20
  15. en:cyclophosphamide-vad regimen -- r_associated #0: 20 / 0.952 -> myélome plasmocytaire
    n1=en:cyclophosphamide-vad regimen | n2=myélome plasmocytaire | rel=r_associated | relid=0 | w=20
≈ 22 relations entrantes

  1. cyclophosphamide --- r_associated #0: 71 --> en:cyclophosphamide-vad regimen
    n1=cyclophosphamide | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=71
  2. en:cyclophosphamide --- r_associated #0: 69 --> en:cyclophosphamide-vad regimen
    n1=en:cyclophosphamide | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=69
  3. en:pomalidomide/bortezomib/dexamethasone regimen --- r_associated #0: 42 --> en:cyclophosphamide-vad regimen
    n1=en:pomalidomide/bortezomib/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=42
  4. en:ixazomib/dexamethasone regimen --- r_associated #0: 41 --> en:cyclophosphamide-vad regimen
    n1=en:ixazomib/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=41
  5. myélome plasmocytaire --- r_associated #0: 40 --> en:cyclophosphamide-vad regimen
    n1=myélome plasmocytaire | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=40
  6. en:plasma cell myeloma --- r_associated #0: 39 --> en:cyclophosphamide-vad regimen
    n1=en:plasma cell myeloma | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=39
  7. en:bendamustine/bortezomib/dexamethasone regimen --- r_associated #0: 38 --> en:cyclophosphamide-vad regimen
    n1=en:bendamustine/bortezomib/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=38
  8. en:carfilzomib/lenalidomide/dexamethasone regimen --- r_associated #0: 37 --> en:cyclophosphamide-vad regimen
    n1=en:carfilzomib/lenalidomide/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=37
  9. en:vad regimen --- r_associated #0: 34 --> en:cyclophosphamide-vad regimen
    n1=en:vad regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=34
  10. en:dpace regimen --- r_associated #0: 30 --> en:cyclophosphamide-vad regimen
    n1=en:dpace regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=30
  11. en:ixazomib/lenalidomide/dexamethasone regimen --- r_associated #0: 30 --> en:cyclophosphamide-vad regimen
    n1=en:ixazomib/lenalidomide/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=30
  12. en:pad regimen --- r_associated #0: 30 --> en:cyclophosphamide-vad regimen
    n1=en:pad regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=30
  13. en:bortezomib/liposomal doxorubicin regimen --- r_associated #0: 29 --> en:cyclophosphamide-vad regimen
    n1=en:bortezomib/liposomal doxorubicin regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=29
  14. en:elotuzumab/bortezomib/dexamethasone regimen --- r_associated #0: 28 --> en:cyclophosphamide-vad regimen
    n1=en:elotuzumab/bortezomib/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=28
  15. en:daratumumab/bortezomib/dexamethasone regimen --- r_associated #0: 26 --> en:cyclophosphamide-vad regimen
    n1=en:daratumumab/bortezomib/dexamethasone regimen | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=26
  16. cyclope (oeil) --- r_associated #0: 15 --> en:cyclophosphamide-vad regimen
    n1=cyclope (oeil) | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=15
  17. Cyclophosphamide --- r_associated #0: 10 --> en:cyclophosphamide-vad regimen
    n1=Cyclophosphamide | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=10
  18. en:cyclops eye --- r_associated #0: 10 --> en:cyclophosphamide-vad regimen
    n1=en:cyclops eye | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=10
  19. myélome (manifestations rénales du) --- r_associated #0: 10 --> en:cyclophosphamide-vad regimen
    n1=myélome (manifestations rénales du) | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=10
  20. cyclopeptide --- r_associated #0: 5 --> en:cyclophosphamide-vad regimen
    n1=cyclopeptide | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=5
  21. cyclophiline --- r_associated #0: 5 --> en:cyclophosphamide-vad regimen
    n1=cyclophiline | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=5
  22. cyclophorie --- r_associated #0: 5 --> en:cyclophosphamide-vad regimen
    n1=cyclophorie | n2=en:cyclophosphamide-vad regimen | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr